Peijia Medical Limited (HKG:9996)
Hong Kong
· Delayed Price · Currency is HKD 5.47
-0.11 (-1.97%)
Jun 6, 2025, 4:08 PM HKT
Peijia Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | 615.48 | 441.13 | 250.83 | 136.53 | 38.66 | Upgrade
|
| Revenue Growth (YoY) | 39.52% | 75.86% | 83.71% | 253.21% | 106.72% | Upgrade
|
| Cost of Revenue | 181.86 | 115.76 | 74.63 | 40.88 | 13.43 | Upgrade
|
| Gross Profit | 433.62 | 325.37 | 176.2 | 95.65 | 25.22 | Upgrade
|
| Selling, General & Admin | 479.44 | 466.62 | 365.06 | 207.68 | 139.1 | Upgrade
|
| Research & Development | 203.42 | 205.5 | 147.02 | 131.3 | 103.37 | Upgrade
|
| Other Operating Expenses | -19.24 | -19.72 | -12.76 | -7.46 | -8.52 | Upgrade
|
| Operating Expenses | 663.62 | 652.4 | 499.32 | 331.52 | 233.95 | Upgrade
|
| Operating Income | -230 | -327.03 | -323.12 | -235.87 | -208.72 | Upgrade
|
| Interest Expense | -4.74 | -0.18 | -2.32 | -0.19 | -0.09 | Upgrade
|
| Interest & Investment Income | 22.48 | 39.44 | 46.63 | 24.77 | 37.3 | Upgrade
|
| Earnings From Equity Investments | - | - | -0.17 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 5.7 | -17.78 | 106.42 | -48.14 | -221.24 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.3 | -1.58 | 0.27 | - | -1,676 | Upgrade
|
| EBT Excluding Unusual Items | -206.25 | -307.13 | -172.28 | -259.42 | -2,068 | Upgrade
|
| Gain (Loss) on Sale of Investments | -14.98 | 3.77 | 0.58 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.37 | -0.22 | -0.03 | -0.22 | -0.38 | Upgrade
|
| Other Unusual Items | - | -87.92 | -226.51 | -314.58 | - | Upgrade
|
| Pretax Income | -221.6 | -391.5 | -398.24 | -574.22 | -2,069 | Upgrade
|
| Income Tax Expense | 6.89 | 1.05 | 9.57 | - | - | Upgrade
|
| Earnings From Continuing Operations | -228.49 | -392.55 | -407.81 | -574.22 | -2,069 | Upgrade
|
| Minority Interest in Earnings | 1.92 | 0.03 | - | - | - | Upgrade
|
| Net Income | -226.58 | -392.53 | -407.81 | -574.22 | -2,069 | Upgrade
|
| Net Income to Common | -226.58 | -392.53 | -407.81 | -574.22 | -2,069 | Upgrade
|
| Shares Outstanding (Basic) | 669 | 679 | 673 | 662 | 467 | Upgrade
|
| Shares Outstanding (Diluted) | 669 | 679 | 673 | 662 | 467 | Upgrade
|
| Shares Change (YoY) | -1.44% | 0.91% | 1.74% | 41.68% | 104.59% | Upgrade
|
| EPS (Basic) | -0.34 | -0.58 | -0.61 | -0.87 | -4.43 | Upgrade
|
| EPS (Diluted) | -0.34 | -0.58 | -0.61 | -0.87 | -4.43 | Upgrade
|
| Free Cash Flow | -254.32 | -806.54 | -506.61 | -506.11 | -206.35 | Upgrade
|
| Free Cash Flow Per Share | -0.38 | -1.19 | -0.75 | -0.77 | -0.44 | Upgrade
|
| Gross Margin | 70.45% | 73.76% | 70.25% | 70.06% | 65.25% | Upgrade
|
| Operating Margin | -37.37% | -74.13% | -128.82% | -172.75% | -539.97% | Upgrade
|
| Profit Margin | -36.81% | -88.98% | -162.58% | -420.57% | -5351.59% | Upgrade
|
| Free Cash Flow Margin | -41.32% | -182.84% | -201.97% | -370.68% | -533.84% | Upgrade
|
| EBITDA | -176.59 | -290.07 | -292.57 | -212.61 | -190.87 | Upgrade
|
| EBITDA Margin | -28.69% | -65.76% | -116.64% | -155.72% | - | Upgrade
|
| D&A For EBITDA | 53.41 | 36.96 | 30.54 | 23.26 | 17.85 | Upgrade
|
| EBIT | -230 | -327.03 | -323.12 | -235.87 | -208.72 | Upgrade
|
| EBIT Margin | -37.37% | -74.13% | -128.82% | -172.75% | - | Upgrade
|
| Advertising Expenses | 77.41 | 67.53 | 48.12 | 14.99 | 5.37 | Upgrade
|
Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.